Chiesi Farmaceutici SpA - Company Profile

Powered by

All the data and insights you need on Chiesi Farmaceutici SpA in one report.

  • Save hours of research time and resources with
    our up-to-date Chiesi Farmaceutici SpA Strategy Report

  • Understand Chiesi Farmaceutici SpA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Chiesi Farmaceutici SpA: Patents

View up-to-date information on Chiesi Farmaceutici SpA patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4059921A1 Application VERFAHREN ZUR HERSTELLUNG EINES PDE4-INHIBITORS A61K31/44; A61K9/007; A61K9/0073; A61P1/00; A61P1/04; A61P11/00; A61P11/02; A61P11/06; A61P11/08; A61P13/12; A61P17/00; A61P17/02; A61P17/10; A61P19/02; A61P25/00; A61P29/00; A61P3/10; A61P35/02; A61P37/02; A61P37/06; A61P37/08; A61P43/00; A61P9/00; A61P9/10; C07B2200/13; C07C205/59; C07C311/08; C07D213/61; C07D213/89 September 21, 2022
CO2022012449A2 Application Inhaladores dosificadores presurizados que comprenden una formulación farmacéutica amortiguada A61K31/167; A61K31/40; A61K31/573; A61K45/00; A61K45/06; A61K47/06; A61K47/10; A61K9/008; A61K9/08; A61M15/00; A61M15/0001; A61M15/002; A61M15/0065; A61M15/009; A61P11/00; A61P11/06; B65D83/14; B65D83/54; B65D83/752 September 09, 2022
EP3527197B1 Grant TROCKENPULVERFORMULIERUNG MIT EINEM CORTICOSTEROID UND EINEM BETA-ADRENERGIKUM ZUR VERABREICHUNG MITTELS INHALATION A61K31/167; A61K31/20; A61K31/57; A61K31/573; A61K47/26; A61K9/0075; A61K9/14; A61K9/145; A61M15/0003; A61M15/003; A61M15/009; A61M2202/064; A61P11/00; A61P11/06; A61P43/00 September 07, 2022
EP3527196B1 Grant TROCKENPULVERFORMULIERUNG MIT EINEM CORTICOSTEROID UND EINEM BETA-ADRENERGIKUM ZUR VERABREICHUNG MITTELS INHALATION A61K31/167; A61K31/20; A61K31/57; A61K31/573; A61K47/26; A61K9/0075; A61K9/14; A61K9/145; A61M15/0003; A61M15/003; A61M15/009; A61M2202/064; A61P11/00; A61P11/06; A61P43/00 September 07, 2022
EP3527199B1 Grant TROCKENPULVERFORMULIERUNG MIT EINEM CORTICOSTEROID UND EINEM BETA-ADRENERGIKUM ZUR VERABREICHUNG MITTELS INHALATION A61K31/167; A61K31/20; A61K31/57; A61K31/573; A61K47/26; A61K9/0075; A61K9/14; A61K9/145; A61M15/0003; A61M15/003; A61M15/009; A61M2202/064; A61P11/00; A61P11/06; A61P43/00 September 07, 2022
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code